Bücher online kaufen
Depression and Type 2 Diabetes
-0 %
Besorgungstitel - wird vorgemerkt | Lieferzeit: Besorgungstitel - Lieferbar innerhalb von 10 Werktagen I
Artikel-Nr:
9780198789284
Veröffentl:
2018
Erscheinungsdatum:
30.10.2018
Seiten:
272
Autor:
Khalida Ismail
Gewicht:
417 g
Format:
231x155x18 mm
Sprache:
Englisch
Beschreibung:
Khalida Ismail, Professor of Psychiatry and Medicine, Department of Psychological Medicine Institute of Psychiatry, Psychology and Neuroscience King's College London, London, UK, Andreas Barthel, Associate Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, Stefan R. Bornstein, Professor of Medicine, Department of Medicine III, University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany, Julio Licinio, Deputy Director, College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA
Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally.
Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes.
Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.
Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes.
Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.
Diabetes and Type-2-Diabetes is a unique resource examining the frequent co-morbidity of diabetes and depression.
- 1: Stefan F. Bornstein, Andreas Birkenfeld, and Julio Licinio: Global burden of diabetes and depression
- 2: Khalida Ismail, Calum D. Moulton, Andrea Danese, and Brenda W. Penninx: A lifecourse approach to understanding the association between depression and type 2 diabetes
- 3: Henning Morawietz, Richard C. Siow, and Mohamad Musbah Almedawar: MicroRNAs as novel biomarkers in depression, diabetes and cardiovascular diseases
- 4: Carol Kan and Ma-Li Wong: Genetics
- 5: Calum D. Moulton and John Pickup: Innate immunity and inflammation in type 2 diabetes-associated depression
- 6: Allan H. Young and Mario F. Jurena: Hypothalamic-Pituitary-Adrenal (HPA) axis
- 7: Carla Petrella, Giuseppe Nistico, and Robert Nistico: Gut-brain axis: physiology
- 8: Norbert Hermanns, Marijke Bremmer, and Frank Snoek: Diabetes distress
- 9: Calum Moulton and Clive Ballard: The association between depression and cognitive impairment in type 2 diabetes
- 10: Frank Petrak and Bonnie Röhrig: Treatment of depression in type 2 diabetes
- 11: Andreas Barthel and Michael Bauer: Risks and benefits of psychotropics
- 12: Lidia Castagneto Gissey, James Casella Mariolo, Geltrude Mingrone, and Francesco Rubino: Metabolic surgery and depression
- 13: Calum Moulton: Novel pharmacological targets
- 14: Harold Lebovitz and Shlomo Ben Haim: Novel technologies
- 15: Christopher Garrett: Current and emerging psychological models
- 16: Eleanor M Scott and Gregory Potter: Targeting the circadian rhythm
- 17: Kirsty Winkley, Ebaa Al-Ozairi, and Boon How Chew: Cultural and global perspectives
- 18: Peter Schwarz and Patrick Timpel: National and international policy initiatives on multi-morbidity